chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Having hallucinations at night when sleeping, very scary things. My hands completed shedding, almost like a snake shedding, front and back down to wrist
Information has been received from a physician concerning a 12 year old male who on 23-JUN-1998 was vaccinated with a first dose of MMR II. On 27-FEB-2001, the patient was vaccinated with a second dose of MMR II (route, site and lots number were not reported). On 06-DEC-2009 the patient experienced the onset of mumps. On 08-DEC-2009 the patient was diagnosed and experienced parotitis. The patient was afebrile. The patient was exposed to other classmate with mumps. On 27-NOV-2009, lab tests revealed: IgM 0.64, IgG, 5.62, and serum amylase 347. On 06-DEC-2009 the patient was diagnosed with mumps. This is one of several reports from the same source. No further information is available.
Clint felt overly warm after second dose of Pfizer Vaccine.  Warm day.  Assisted to cot by a nurse. Vital Signs taken : BP 118/78 Pulse 74. Pulse Oximeter 97% Rested on cot and drank water.
Fever up to 103 for 36 hours treatable with Tylenol, couldn?t get out of bed. Headache, chills, general flu like symptoms. Feel better 48 hours later. Left with red, swollen arm that is warm to the touch. It is red and splotchy.
PT WENT UNRESPONSIVE 5 MINUTES AFTER THE VACCINE. BP BARELY DETECTABLE. HR 44. FAINT. PT APPEARED PALE AND DIAPHORETIC. ADMINISTERED EPI 3MG IM. PT OPENED HER EYES AND STARTED RESPONDING VERY SLOWLY. FEELING SLIGHTLY BETTER AFTER 5 MINUTES. TRANSFERRED FROM CHAIR TO EXAM BED W/ MIN ASSIST.  BP 84/44. HR 64. PARAMEDICS ARRIVED. PT RETAINED CONSCIOUSNESS. DECLINED TO BE TRANSFERRED TO ED. PARAMEDICS STAYED WITH HER FOR 10 MIN. SHE VERBALIZED COMPLETE RECOVERY. STANDING AND WALKING INDEPENDENTLY. DENIES DIZZINESS OR WEAKNESS.
Tested positive for COVID on 11/7/22 - felt tired and took several naps on 11/6/22, husband was positive on the evening of 11/6/22.  More naps on 11/7/22.  Mild cough throughout, mild headache about day 4 + 5, low grade (never higher than 100.4) day 2-5
This spontaneous report as received from a nurse refers to a female patient of unknown age. On an unknown date the patient was vaccinated with a first dose of GARDASIL (dose: 0.5 ml, intramuscularly, lot # and expiration date not reported). Three weeks later (date unknown) the patient was vaccinated with a second dose of GARDASIL (dose: 0.5 ml, intramuscularly, lot# and expiration date not reported). No adverse effects reported. Additional information has been requested.
I has a sore arm at the injection site. I tested positive via a home test for COVID-19 on 09/11/2022. I had the following symptoms which was a fever, body aches, cough, runny nose, sneezing and stomach upset. I started taking ibuprofen; aspirin; guaifenesin and phenylephrine.
Patient received two doses of Janssen vaccine. No adverse event has been noticed at the time of reporting.  Patient is an inmate at the time of administration of the second dose of vaccine on 07/21/2021. When asked if the individual had received a COVID-19 vaccine, he stated he had not. The first dose was administered on 03/26/2021.
Patient later disclosed she had hives with last Pfizer shot, and also hand tingling. Observation time switched to 30 minutes. She had hand tingling "like it's falling asleep" in the right hand about 20 minutes after the vaccine, but it went away. Her left hand was still tingling. 50mg diphenhydramine PO administered. About 20 minutes later, still tingling but less so. Patient did not wish to proceed to urgent care and left observation. No difficulty breathing or facial swelling. Followed-up with patient via phone 2 hours later. She stated immediately after leaving, her face broke out in hives but since resolved. Never any throat or lip swelling or difficulty breathing. Tingling in hand has not resolved. Recommended follow-up if symptoms do not abate.
fever nausea fatigue headache neck pain back pain began within 24 hrs of vaccine administration treatment- Tylenol, motrin supportive care intravenous fluids IV ceftriaxone x 2 days
Information has been received from a physician via Company representative concerning to a patient of unknown age and gender (Encounter key# 102632). Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 31-AUG-2015, the patient was vaccinated with an improperly stored dose of GARDASIL "10x1 sdv" (Lot No. K001631, exp. 24-FEB-2017) (dose and site not reported). On an unspecified dates, the GARDASIL vaccine had six temperature excursions: 24, 80, 1172, 168, 416 and 336 respectively. The lowest recorded temperature were 30 (-1.111111111 Celsius), and -3 (-3 Celsius) and the highest recorded temperature were 49 (9.444444444 Celsius), 47 (8.333333333) and 59 (15 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as Refrigerator (R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
sudden sleep/unresponsiveness, 5 mins p/vax; nl HR & capillary filling; very difficult to arouse (but good color & tone) for 40 minutes, then suddenly aroused, was alert & fully wakeful;
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2022 at 2:35 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 24-Jan-2022 at 2:35 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was not reported. Patient received booster dose on 24 Jan 2022 at 2:35 PM.  A series of patients approximately 540 patients received lot 066H21A past its 30-day expiry date. Vaccines went into 2-8 c thaw state on or above 24-Dec-2021. This vaccine was administered up until its manufacturer expiry date of 04-Apr-2022.  No treatment medications were provided.
Patient contacted reporter at the Employee flu clinic on 11/03/15. He reported swelling and a hard bump at the injection site that was observed on 10/28/15. He currently has a purple skin discoloration at the injection site, swelling, bump size decreasing and sore arm. Recommend seek medical care if pain continues. 11/6 PHN call to EMS. Patient moving up to upper arm and shoulder. Recommend see healthcare provider.
Constant, steady pitch/tone tinnitus occurring roughly 24 hours after the shot. May have been sooner but I didn't notice it until roughly 24 hours later.
Pt received PNEUMOVAX 0.5cc IM Rt deltoid on 8-22-13. Pt complained of pain. Instructed him to medicate with APAP or ibuprofen. Pain increased. Pt went to hospital ER 8-24-13 was hospitalized with cellulitis.
tested positive for COVID; tested positive for COVID; Fever; FACILITATED COLLECT  This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 22K-163-4267840-00 (AbbVie).  A 15 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 27Jan2022 (Batch/Lot number: unknown) at the age of 15 years as dose 2, single and intramuscular (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (ongoing) (Batch/Lot number: unknown) at citrate free. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 28Jan2022, outcome "recovered" (2022) and all described as "tested positive for COVID"; PYREXIA (non-serious) with onset 2022, outcome "unknown", described as "Fever". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (28Jan2022) positive. The action taken for adalimumab was dosage not changed.  Causality for Humira (Adalimumab) The reporter's causality for the event(s) of tested positive for covid and fever was not provided. Causality 1) COVID-19 virus test positive (SARS-CoV-2 test positive), Action(s) taken with drug: Dose Not Changed, Causality as per reporter (Drug/Vaccine) : Not Reported, Dechallenge: N/A 2) Fever (Pyrexia), Action(s) taken with drug: Dose Not Changed, Causality as per reporter (Drug/Vaccine): Not Reported, Dechallenge: N/A 2) Pfizer BioNTech Covid-19 Vaccine (Tozinameran) (Tozinameran), Unknown, Unknown, Daily Dose: 1st dose (1 in - Route of administration: Intramuscular, Indication for use: Covid-19 vaccination, Therapy dates: Unk Seq.No. :2 Drug: Pfizer Biontech covid-19 vaccine (Tozinameran)(Tozinameran), Unknown, Unknown, Daily Dose: 1) 1st dose (1 in 1 Once), 2) Second Dose (1 in 1 Once), Route of Admin: 1) Intramuscular 2) Intramuscular, Therapy Dates/Duration: 2) 27Jan2022 - 27Jan2022 Causality: 1) COVID-19 virus test positive (SARS-CoV-2 test positive), Action(s) taken with drug: Unknown, Causality as per reporter (Drug/Vaccine): Not Reported, Dechallenge: N/A 2) Fever (Pyrexia), Action(s) taken with drug:  Unknown, Causality as per reporter (Drug/Vaccine): Not Reported, Dechallenge:  N/A  The reporter's assessment of the causal relationship of the (drug ineffective, COVID-19, pyrexia) with the suspect product was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: The events of Drug Ineffective, COVID-19 and pyrexia are related to the suspect product BNT162B2 based on temporal relationship.
1) She reports that her hot flashes disappeared immediately after her vaccine. She has had hot flashes for years.  2) She reports having  SOB, spider veins, and Rt sided chest/breast pain which began 48 hours after her vaccination. She is "sure" that this is from the vaccine. She has "severe emphysema" on CT(chest) as well as bronchiectasis, but with relatively unremarkable PFTs. This was investigated due to her elevated d-dimer.  No PE evident. She is quite anxious about the possibility of a vaccine reaction. Awaiting respirology referral due to her newly found bronchiectasis & COPD(?).
Right armpit has a swollen area approx 5inchesx3inches. Severe lymph node swelling. Not red, not hot to touch, not painful.
Severe redness, swelling, heat, discomfort of L arm where shots were given.
Information has been received from a mother concerning her 22 year old female daughter with colitis and allergies to Ceclor, who on 20-SEP-2008 was vaccinated with the second dose of GARDASIL. Concomitant therapy included hormonal contraceptives (unspecified) and ASACOL. The mother reported that her daughter developed a fever, nausea, vomiting and a rash on her chest about 8 hours after receiving her second dose of GARDASIL. The patient sought medical attention by a phone call. At the time of report the patient had not recovered. Additional information has been expected.
Fever x 3 days, malaise x 5 days, arm swelling x 2 weeks, rash x 2 weeks
Body aches, site red, hot, itchy, firmness under skin. Symptoms started within hrs of injection. Persisted x 72 hrs. Itchiness & soreness x 1 week.
Mom first called for swelling at Rt thigh on 04-08-2008. It was non tender, non erythmatous swelling without any fever or irritability. On 04-14-2008 Mom reported that swelling is getting red and tender without any fever. On examination local infection with possibility of developing abscess. With parents agreement patient is placed in Augmentin 600 mg/5 ml, 3 ml po bid. Will follow in 48 hr / earlier if patient gets worse. Today patient is still afebrile. Parents were explained about possible need for hospital admission and drainage if get worse and report if any fever or patient getting worse.  This batch number is very close that of recalled batch of Comvax 0376 and 0387U. Was there is any contamination of this batch with same bacteria?
Lightheaded/Dizzy; Off balance; feel like you had too much to drink; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheaded/Dizzy), BALANCE DISORDER (Off balance) and FEELING DRUNK (feel like you had too much to drink) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced DIZZINESS (Lightheaded/Dizzy), BALANCE DISORDER (Off balance) and FEELING DRUNK (feel like you had too much to drink). At the time of the report, DIZZINESS (Lightheaded/Dizzy), BALANCE DISORDER (Off balance) and FEELING DRUNK (feel like you had too much to drink) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a registered nurse refers to a female patient of unknown age. On 24-AUG-2011 the patient was vaccinated with GARDASIL first dose. No concomitant medications were reported. On 24-JAN-2014, the patient visited the clinic to receive her second dose of GARDASIL. No adverse effects reported. No PQC involved. Additional information has been requested.
Pain and swelling at the injection site.; Pain and swelling at the injection site.; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 06Dec2021 10:45 (Lot number: FH8027) at the age of 63 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EP-6955, Location of injection: Arm Right, Route of Administration: Intramuscular), administration date: 24Mar2021, when the patient was 63 years old, for Covid-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247, Location of injection: Arm Right, Route of Administration: Intramuscular), administration date: 01Mar2021, when the patient was 63 years old, for Covid-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 06Dec2021 10:45, outcome "unknown", described as "booster"; VACCINATION SITE SWELLING (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 07Dec2021 05:30, outcome "recovering" and all described as "Pain and swelling at the injection site.". Therapeutic measures were not taken as a result of vaccination site swelling, vaccination site pain.  Additional information: reported seriousness was reported as non-serious. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with covid-19 prior to vaccination. Since the vaccination patient was not tested for covid-19.  No follow-up attempts are possible. No further information is expected.
Information has been received from a consumer regarding her husband, a 76 year old male patient, enrolled in a Market Research Program. The patient's concurrent condition, medical history and concomitant therapy were not reported. On an unknown date in 2006, the patient and his wife were vaccinated with ZOSTAVAX (dose, strength, total daily dose and therapy route were not reported). The patient's wife reported that their doctor ordered another shingles shot even when the doctor knew that they had had a shingles shot. They trusted that the doctor knew what he was doing and received another shot on 27-APR-2016 from a nurse, who informed them that shingles vaccine shot was given only once in lifetime. The patient and his wife were having bad side effects, as of the time of the report. They were 72 and 76 years and the patient's wife asked about what they might need to know regarding this issue. No further information was reported. The action taken with ZOSTAVAX was not applicable. The outcome of the event, very bad side effects was not recovered. The causality of the event, very bad side effects to ZOSTAVAX and study procedure was not reported. The reporter considered the event very bad side effects to be serious (details unknown, considered as medically significant). The case is linked to MARRS# 1605USA003796 via same reporter link.
pt recv vax & took APAP 10PM-1230AM up to go to BR arm hurt apparently passed out, husband said wasn't breathing, face drawn to side;felt weak all over, body shakey, breathing shallow to ER via amb;t99.6;CT, EEG, blood work WNL;lt arm numb;
Received shot sitting down. All was fine. Walked down long hallway to observation room. Spoke to nurse who told us to sit for 15 min. Sat down he started to sweat profusely. Told him to take his sweatshirt off. Continues to sweat his forehead his T-shirt was wet his back was wet. Then he tilted his head back his eyes rolled back into his head. I called the nurse. We got him to a wheelchair and behind the curtain. Before we had a chance to put him on the Exam Table he passed out and started to seize for the count of 3 or 4 seconds. Then he woke up. He said he saw white beautiful light. I am not kidding. He does not joke. Then he said he was fine. Insisted he was fine.  His bp was low for the first two readings. Then It came back up to normal. He laid flat for 15 more min. Had some juice. Sat up when It was gone to go. Bp got super high. We waited till It was normal and left.
AFTER PATIENT RECEIVED THE DOSE OF COVID VACCINE JOHNSON AND JOHNSON HE WAITED FOR 15 MINUTES AND WHEN HE STOOD UP, HE COLLAPSED BUT HE WAS CONSCIOUS, WE HELPED HIM AND PUT HIM BACK ON A CHAIR  AND HE PASSED OUT FOR 3 TO 5 SECONDS AFTER THAT HE STARTED FEELING BETTER BUT STILL VERY COLD AND PALE. WE ASKED HIM TO WAIT FOR OTHER 30 MINUTES AND AFTER THAT HE FELT OK.
Fever, (101), chills, muscle aches. Arm is swollen, hot to the touch, red.  Has lasted over 24 hrs. Taking Ibuprofen, which helps.
temperature excursion on GARDASIL 9; No other adverse events - No signs or symptoms reported; Information has been received from a registered nurse reporting on a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication.  On an unknown date, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 0.5 mL for prophylaxis, lot# 1687293 and expiration date reported as 25-AUG-2022, but upon internal validation was established as 30-APR-2023 (route of administration not reported). No adverse events were reported.  On an unknown date, the vaccine underwent a temperature excursion of 47.1 Fahrenheit degree for 13 minutes. No previous temperature excursions were reported. The call was not placed because a digital data logger.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1687293; expirationdate: 30-APR-2023; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2103USA005285: US-009507513-2104USA003211: US-009507513-2104USA003212: US-009507513-2104USA003213: US-009507513-2104USA003214: US-009507513-2104USA003215: US-009507513-2104USA003216: US-009507513-2104USA003217: US-009507513-2104USA003218: US-009507513-2104USA003219: US-009507513-2104USA003220: US-009507513-2104USA003221: US-009507513-2104USA003222: US-009507513-2104USA003223: US-009507513-2104USA003224: US-009507513-2104USA003225: US-009507513-2104USA003196: US-009507513-2104USA003197: US-009507513-2104USA003198: US-009507513-2104USA003199: US-009507513-2104USA003200: US-009507513-2104USA003201: US-009507513-2104USA003202: US-009507513-2104USA003203: US-009507513-2104USA003204: US-009507513-2104USA003205: US-009507513-2104USA003210: US-009507513-2104USA003207: US-009507513-2104USA003208: US-009507513-2104USA003209:
Soreness of arm ,The following day I woke up and felt fine and cup of coffer I felt nauseated , headache, Took Advil and headache was worse.. The following day I still had a really bad headache and felt nauseated .
Two days of symptoms, starting with sore arm 30 minutes after injection & lasting  3 days. A few hours after injection, malaise, loss of appetite, fever & chills, lasting approximately 1 1/2 days. When I had the second dose (03/04/2019), symptoms of similar duration, but not quite as severe.
PT HAD INTERMITTENT BRADYCARDIA, LOW BP AND ALTERED CONSCIOUSNESS.
A report was received from a healthcare professional concerning a 55-year-old female vaccinee.  No details concerning the vaccinee's past medical history were provided. On 07/Nov/2006 the vaccinee was administered influenza vaccine (brand unspecified) and Pneumovax 23, 0.5 ml subcutaneously in separate sites (not specified).  In November 2006, the patient was hospitalized for treatment with IV antibiotics because she developed a cellulitis shortly after vaccination.  The cellulitis was unresponsive to oral antibiotics, the vaccinee was discharged from the hospital on 16/Nov/2006.  The event outcome was not provided.  The reporter considered the events to be serious due to hospitalization and also medically significant. (OMIC)